New treatments and approaches for attention deficit hyperactivity disorder.
Newcorn
J H
JH
Department of Psychiatry, Mount Sinai School of Medicine, Box 1230, One Gustave L. Levy Place, New York, NY 10029, USA. Jeffrey.Newcorn@MSSM.edu
D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000639:trends; D006801:Humans; D011437:Propylamines / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride